Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer
Authors
Keywords
Neutrophil-to-lymphocyte ratio, Serous ovarian cancer, Chemotherapeutic sensitivity, Prognosis
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 75, Issue 2, Pages 255-262
Publisher
Springer Nature
Online
2014-12-01
DOI
10.1007/s00280-014-2622-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer
- (2014) N.G. Alkema et al. GYNECOLOGIC ONCOLOGY
- Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer
- (2014) Kristina A. Williams et al. GYNECOLOGIC ONCOLOGY
- Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients
- (2014) Peng Xue et al. Cancer Medicine
- Elevated Preoperative Systemic Inflammatory Markers Predict Poor Outcome in Localized Soft Tissue Sarcoma
- (2013) Eun-Seok Choi et al. ANNALS OF SURGICAL ONCOLOGY
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients
- (2013) Basem Azab et al. MEDICAL ONCOLOGY
- A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG
- (2012) S. Banerjee et al. ANNALS OF ONCOLOGY
- Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal Cancer
- (2011) Reem Z. Sharaiha et al. ANNALS OF SURGICAL ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
- (2011) Viren Asher et al. Clinical & Translational Oncology
- Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
- (2010) Yue Wang et al. CANCER LETTERS
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
- (2010) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Pretreatment Neutrophil-to-Lymphocyte Ratio as an Independent Predictor of Recurrence in Patients With Nonmetastatic Renal Cell Carcinoma
- (2010) Yoshio Ohno et al. JOURNAL OF UROLOGY
- Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
- (2008) HanByoul Cho et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started